Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: Past, present, and future
Authors:
- 17 December 2009
- journal article
- review article
- Published by Taylor & Francis in Autoimmunity
- Vol. 43 (1) , 84-97
Abstract
It has long been known that B cells produce autoantibodies and, thereby, contribute to the pathogenesis of many autoimmune diseases. Systemic lupus erythematosus (SLE), a prototypic systemic autoimmune disorder, is characterized by high-circulating autoantibody titers and immune-complex deposition that can trigger inflammatory damage in multiple organs/organ systems. Although the interest in B cells in SLE has historically focused on their autoantibody production, we now appreciate that B cells have multiple autoantibody-independent roles in SLE as well. B cells can efficiently present antigen and activate T cells, they can augment T cell activation through co-stimulatory interactions, and they can produce numerous cytokines which affect inflammation, lymphogenesis, and immune regulation. Not surprisingly, B cells have become attractive therapeutic targets in SLE. With these points in mind, this review will focus on the autoantibody-dependent and autoantibody-independent roles for B cells in SLE and on therapeutic approaches that target B cells.Keywords
This publication has 160 references indexed in Scilit:
- A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosusArthritis Care & Research, 2009
- Novel evidence‐based systemic lupus erythematosus responder indexArthritis Care & Research, 2009
- CD22: an inhibitory enigmaImmunology, 2008
- The ‘short’ history of regulatory B cellsTrends in Immunology, 2008
- Rituximab therapy for juvenile-onset systemic lupus erythematosusPediatric Nephrology, 2007
- Type-I interferons and systemic lupus erythematosusAutoimmunity Reviews, 2006
- Selective dysregulation of the FcγIIB receptor on memory B cells in SLEJournal of Experimental Medicine, 2006
- Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosusImmunology, 2006
- Fine-Mapping Chromosome 20 in 230 Systemic Lupus Erythematosus Sib Pair and Multiplex Families: Evidence for Genetic Epistasis with Chromosome 16q12The American Journal of Human Genetics, 2006
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004